Itau Unibanco Holding S.A.’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
Other funds holding CERE
Itau Unibanco Holding S.A.'s CERE Position: Q3 2024 in Review
Itau Unibanco Holding S.A. sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 100 shares — an estimated $4.09K sold.
Itau Unibanco Holding S.A. first reported a position in CERE in Q2 2022 and held it in 8 quarters. The position peaked at $4.09K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.
- Itau Unibanco Holding S.A. reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Itau Unibanco Holding S.A. sold 100 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $4.09K.
- Itau Unibanco Holding S.A. first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
- Itau Unibanco Holding S.A.'s Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $4.09K in Q2 2024.
- 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.
Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.